WO/2004/016617 is referenced by 40 patents.

Nicotinic acetylcholine receptor of formula (I) wherein D, Ar1, E and Ar2 are as defined in the specification, enantiomers, pharmaceutically acceptable salts, methods of making, pharmaceutical compositions containing and methods for using the same in the treatment or prophylaxis of psychotic disorders, intellectual impairment disorders, Alzheimer’s disease, learning deficit, cognition deficit, attention deficit, memory loss, Lewy Body Dementia, Attention Deficit Hyperactivity Disorder, anxiety, schizophrenia, mania or manic depression, Parkinson’s disease, Huntington’s disease, Tourette’s syndrome, neurodegenerative disorders in which there is loss of cholinergic synapse, jetlag, cessation of smotking, nicotine addiction, pain, ulcerative colitis or irritable bowel syndrome.

Title
Biaryl diazabicycloalkane amides as nicotinic acetylcholine agonists
Application Number
PCT/SE2003/001277
Publication Number
2004/016617
Application Date
August 13, 2003
Publication Date
February 26, 2004
Inventor
Schmiesing Richard
Phillips Eifion
Ernst Glen
Agent
ASTRAZENECA
Assignee
Schmiesing Richard
Phillips Eifion
Ernst Glen
Astrazeneca
IPC
C07D 471/08
A61K 31/551
View Original Source